Involvement of Holliday junction resolvase in fluoroquinolone-mediated killing of Mycobacterium smegmatis

Antimicrob Agents Chemother. 2015 Mar;59(3):1782-5. doi: 10.1128/AAC.04434-14. Epub 2014 Dec 22.

Abstract

The absence of the Holliday-junction Ruv resolvase of Mycobacterium smegmatis increased the bacteriostatic and bactericidal activities of the fluoroquinolone moxifloxacin, an important antituberculosis agent. The treatment of ruvAB-deficient cells with thiourea and 2,2'-bipyridyl lowered moxifloxacin lethality to wild-type levels, indicating that the absence of ruvAB stimulates a lethal pathway involving reactive oxygen species. A hexapeptide that traps the Holliday junction substrate of RuvAB potentiated moxifloxacin-mediated lethality, supporting the development of small-molecule enhancers for moxifloxacin activity against mycobacteria.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / pharmacology
  • DNA, Cruciform / drug effects
  • DNA, Cruciform / metabolism
  • DNA-Binding Proteins / metabolism
  • Fluoroquinolones / pharmacology*
  • Holliday Junction Resolvases / metabolism*
  • Moxifloxacin
  • Mycobacterium smegmatis / drug effects*
  • Mycobacterium smegmatis / metabolism*
  • Reactive Oxygen Species / metabolism
  • Thiourea / pharmacology

Substances

  • Antitubercular Agents
  • DNA, Cruciform
  • DNA-Binding Proteins
  • Fluoroquinolones
  • Reactive Oxygen Species
  • Holliday Junction Resolvases
  • Thiourea
  • Moxifloxacin